Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Pim Rozendal"'
Autor:
Astrid Kramer, Ed Schuuring, Daan C.L. Vessies, Paul van der Leest, Maartje J. Geerlings, Pim Rozendal, Mirthe Lanfermeijer, Theodora C. Linders, Léon C. van Kempen, Remond J.A. Fijneman, Marjolijn J.L. Ligtenberg, Gerrit A. Meijer, Daan van den Broek, Valesca P. Retèl, Veerle M.H. Coup
Publikováno v:
Journal of molecular diagnostics, 25(1), 36-45. ELSEVIER SCIENCE INC
Journal of Molecular Diagnostics, 25, 36-45
Journal of Molecular Diagnostics, 25, 1, pp. 36-45
Journal of Molecular Diagnostics, 25, 36-45
Journal of Molecular Diagnostics, 25, 1, pp. 36-45
Contains fulltext : 291298.pdf (Publisher’s version ) (Open Access) Circulating tumor DNA (ctDNA) is a promising new biomarker with multiple potential applications in cancer care. Estimating total cost of ctDNA testing is necessary for reimbursemen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::639d683f73a8fa5170e187b066c744a1
https://research.rug.nl/en/publications/aee6f337-2803-4725-a091-1b057568759b
https://research.rug.nl/en/publications/aee6f337-2803-4725-a091-1b057568759b
Autor:
Astrid Kramer, Ed Schuuring, Daan Vessies, Paul van der Leest, Maartje Geerlings, Pim Rozendal, Mirthe Lanfermeijer, Theodora Linders, Léon van Kempen, Remond Fijneman, Marjolijn Ligtenberg, Gerrit Meijer, Daan van den Broek, Valesca Retèl, Veerle Coupé
Publikováno v:
International Journal of Technology Assessment in Health Care. 38:S56-S57
IntroductionCirculating tumor DNA (ctDNA) is a promising new biomarker with multiple potential applications in cancer care. As part of the “ctDNA on the way to implementation in the Netherlands (COIN)” project, an early, comprehensive Health Tech
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4db298a21e07ac6d01cc19430d28094
https://doi.org/10.1017/s026646232200188x
https://doi.org/10.1017/s026646232200188x